Advertisement
Advertisement
BTTC
Black Titan Corporation Ordinary Shares
0.32
USDSponsored
+0.01
+4.42%
Nov 13, 15:53 UTC -5
Closed
After-Market
0.30
-0.01
-4.24%
Black Titan Corporation Ordinary Shares (BTTC) Earnings
BTTC Earnings Reports
Positive Surprise Ratio
No Data Available for BTTC
0%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Black Titan Corporation Ordinary Shares earnings per share and revenue
On Aug 12, 2026, BTTC reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Pelthos Therapeutics Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$2.20
Actual
-$3.09
Surprise
-39.99%

Biofrontera Inc. Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.11
Actual
-$0.42
Surprise
-274.33%

Actuate Therapeutics, Inc. Common stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.14
Surprise
+19.26%

Acurx Pharmaceuticals, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.38
Actual
-$0.49
Surprise
-27.54%

Parabilis Medicines, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.40
Actual
-$0.36
Surprise
+10.27%

Avalyn Pharma Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.67
Surprise
+7.92%

Inhibrx Biosciences, Inc. Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$2.57
Actual
-$2.46
Surprise
+4.41%

Sagimet Biosciences Inc. Series A Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.31
Surprise
-17.03%

Monopar Therapeutics Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.88
Actual
-$0.72
Surprise
+18.81%

TuHURA Biosciences, Inc. Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.10
Surprise
+28.72%
FAQ
What were Black Titan Corporation Ordinary Shares's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Black Titan Corporation Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Black Titan Corporation Ordinary Shares's Q2 2026 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Black Titan Corporation Ordinary Shares expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Black Titan Corporation Ordinary Shares's next earnings report?
Based on --
analysts, Black Titan Corporation Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.